There are reasons MK's submissions are being slow walked now and half the reviewers are new. Read prior RDGL downdates. Typically, MK closes a meeting insulting the reviewers for delays instead of focusing on getting FDA what's needed for them to consider Radiogel for human trials. Worse than that, he has resisted and foot dragged against FDA suggestions going back years now. Likewise, he has never replied to FDA comments in a timely fashion, often taking over a year.
If RDGL isn't in a rush, why should FDA be?
News 
Market Data 
Discover 
